Koos Boeve

198 Chapter 9 94. Ramos-Garcia P, Gonzalez-Moles MA, Ayen A, Gonzalez-Ruiz L, Ruiz-Avila I, Gil-Montoya JA. Prognostic and clinicopathological significance of CTTN/ cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta-analysis. Head Neck 2019 Jun;41(6):1963-1978. 95. Morand GB, Ikenberg K, Vital DG, Cardona I, Moch H, Stoeckli SJ, et al. Preoperative assessment of CD44-mediated depth of invasion as predictor of occult metastases in early oral squamous cell carcinoma. Head Neck 2019 Apr;41(4):950-958. 96. Leusink FK, van Es RJ, de Bree R, Baatenburg de Jong RJ, van Hooff SR, Holstege FC, et al. Novel diagnostic modalities for assessment of the clinically node-negative neck in oral squamous- cell carcinoma. Lancet Oncol 2012 Dec;13(12):e554-61. 97. Fortuin AS, Bruggemann R, van der Linden J, Panfilov I, Israel B, Scheenen TWJ, et al. Ultra-small superparamagnetic iron oxides for metastatic lymph node detection: back on the block. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2018 Jan;10(1):10.1002/wnan.1471. Epub 2017 Apr 6. 98. Fortuin AS, Deserno WM, Meijer HJ, Jager GJ, Takahashi S, Debats OA, et al. Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases. Int J Radiat Oncol Biol Phys 2012 Nov 1;84(3):712-718. 99. Heesakkers RA, Hovels AM, Jager GJ, van den Bosch HC, Witjes JA, Raat HP, et al. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol 2008 Sep;9(9):850-856. 100. Baghi M, Mack MG, Hambek M, Rieger J, Vogl T, Gstoettner W, et al. The efficacy of MRI with ultrasmall superparamagnetic iron oxide particles (USPIO) in head and neck cancers. Anticancer Res 2005 Sep- Oct;25(5):3665-3670. 101. Agrawal A, Civantos FJ, Brumund KT, Chepeha DB, Hall NC, Carroll WR, et al. (99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi- institutional Trial. Ann Surg Oncol 2015 Oct;22(11):3708-3715. 102. Marcinow AM, Hall N, Byrum E, Teknos TN, Old MO, Agrawal A. Use of a novel receptor-targeted (CD206) radiotracer, 99mTc-tilmanocept, and SPECT/CT for sentinel lymph node detection in oral cavity squamous cell carcinoma: initial institutional report in an ongoing phase 3 study. JAMA Otolaryngol Head Neck Surg 2013 Sep;139(9):895-902. 103. Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 1994 Jan 1;73(1):187-190. 104. Licciardello JT, Spitz MR, Hong WK. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys 1989 Sep;17(3):467-476. 105. de Boer E, Harlaar NJ, Taruttis A, Nagengast WB, Rosenthal EL, Ntziachristos